Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Demineralized collagen refers to the residual organic extracellular matrix, mainly type I collagen, remaining after removal of mineral (primarily hydroxyapatite) from tissues such as bone or dentin[3][4]. This process preserves a protein-rich scaffold that is osteoinductive, containing growth factors and proteins that can induce dentin or bone formation by recruiting and differentiating progenitor cells[3][4]. Demineralized dentin matrix (DDM) is a well-studied application, used widely in regenerative dentistry to enhance pulp, dentin, and alveolar bone healing[3].\n\nEtched hydroxyapatite is hydroxyapatite (the main mineral in bone and teeth) that has been treated with acids (e.g., phosphoric acid in dentistry) to increase its surface porosity and surface area[1]. Etching exposes additional binding sites and microstructures on HAp, improving its ability to anchor adhesives, cells, or new mineral layers[1][4]. The process is critical for dental restorative procedures to optimize bonding and integration of restorative materials[1].\n\nBoth materials are central in tissue engineering and dental regenerative procedures but are not molecular drug targets or receptors.\nThey are biomaterial surfaces or scaffolds, not proteins, enzymes, or receptors in the classical sense of pharmacological targeting.\n\nKey points:\n- Not molecular pharmacological targets; more accurately described as biomaterial surfaces or scaffolds.\n- Used to support regeneration by providing biological or structural cues to cells.\n- Variability and undefined nature (not a single molecule or protein) make structured target curation inappropriate.\n- Their biological effects depend on surface characteristics, preparation method, and interaction with surrounding tissues, not drug-receptor interactions[3][4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Demineralized collagen and etched hydroxyapatite.